Contact Us

CBM Wins Inaugural PHL Inno Madness

CBM has extensive Plasmid DNA and Autologous Cell Therapy Manufacturing capabilities.
March 29, 2022

After four weeks of competition, PHL Inno Madness has a champion. The Center for Breakthrough Medicines claimed the inaugural title in a tightly contested final matchup with Philadelphia real estate startup Houwzer.

Seeded No. 1 in the life sciences region of the bracket, the King of Prussia-based Center for Breakthrough Medicines (CBM) was one of the favorites to come through – and it did. The cell and gene therapy contract development and manufacturing organization (CDMO) was the only one of the four top seeds to survive beyond the second round of the competition.

Read Full Story

Contact Us Now